Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Impressive panic

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Dec 07, 2022 5:36pm

141 Views

Post# 35157589

RE:RE:RE:Impressive panic

To my surprise some of the people I recomended Thera to years ago have had enough and panic sold for a loss over the last couple of days, the down side to recomending investmenst to family and fiend is you own it & the results.....after this I will refrane from any recomendations.

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire